Clobazam and Ethosuximide interaction
Clobazam and Ethosuximide: the Clobazam prescribing label describes an interaction that usually calls for monitoring, a dose change, or spacing the doses.
Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.
What the FDA labels say
From the Clobazam (SYMPAZAN) label · effective 2025-12-01
Risk may be increased with concomitant use of other CNS depressants ( 5.4 , 5.5 )
Prescribers should monitor patients for somnolence and sedation, particularly with concomitant use of other central nervous system depressants.
Therefore, caution patients or their caregivers against simultaneous use with other CNS depressant drugs or alcohol, and caution that the effects of other CNS depressant drugs or alcohol may be potentiated [see Warnings and Precautions (5.4) ].
Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.
Open in the checkerNot medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.